Positive Ph3 Data for Aspergillosis Antifungal Treatment
Phase 3 trial results indicate a new antifungal medication olorofim is as effective as current standard treatments for invasive aspergillosis with fewer side effects.
Phase 3 trial results indicate a new antifungal medication olorofim is as effective as current standard treatments for invasive aspergillosis with fewer side effects.
Phase 3 trial results indicate a new antifungal medication olorofim is as effective as current standard treatments for invasive aspergillosis with fewer side effects.
Read MoreSampling sewage lines directly serving healthcare facilities allows scientists to identify...
Read MoreParticipants with no prior exposure to SARS-CoV-2 experienced fewer vaccine side effects and continued increases in antibody levels over six months.
Read MoreA new class of molecules called coniotins bind to the fungal cell wall, disrupting its structural integrity and reducing the pathogen’s ability to survive.
Read MoreA new study has linked mold exposure in the home to hypersensitivity pneumonitis, revealing a significant and under-recognized risk factor.
Read MorePeople with diabetes, COPD, or co-infections such as COVID-19, tuberculosis or flu, are at higher risk of developing fungal infections.
Read MorePneumonia is a potentially life-threatening infection of the lungs that inflames alveoli and spurs the overproduction of purulent material. Typically afflicting neonates and seniors, the COVID pandemic has revealed the importance of proper pneumonia care for all patients.
Read MoreEpidemiological data indicates that a rise in severe fungal infections has resulted in over 150 million cases annually and almost 1.7 million fatalities globally.
Read MoreA study of fungal lung infections found that P. aeruginosa works with fluconazole to eliminate drug tolerance and clear Candida albicans infections.
Read MoreCystic fibrosis can be a devastating, even fatal, disease; but proper diagnosis and new treatments, coupled with breakthroughs in gene replacement therapy, offer improved outcomes.
Read More